Cannara Biotech Inc. LOVFF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.90M | 7.32M | 8.42M | 9.35M | 11.14M |
| Total Depreciation and Amortization | 4.90M | 4.61M | 4.80M | 4.80M | 4.46M |
| Total Amortization of Deferred Charges | 156.70K | 156.70K | 71.30K | 36.90K | 209.30K |
| Total Other Non-Cash Items | 7.93M | 8.17M | 7.37M | 4.66M | 202.90K |
| Change in Net Operating Assets | -6.84M | -462.10K | -4.80M | -4.44M | -1.34M |
| Cash from Operations | 14.04M | 19.80M | 15.87M | 14.41M | 14.67M |
| Capital Expenditure | -9.94M | -8.30M | -6.97M | -4.55M | -3.84M |
| Sale of Property, Plant, and Equipment | 204.00K | 215.30K | 113.40K | 115.60K | 21.90K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.75M | 205.90K | 192.00K | 178.60K | 151.40K |
| Cash from Investing | -11.48M | -7.88M | -6.67M | -4.26M | -3.67M |
| Total Debt Issued | 2.00M | 0.00 | 0.00 | 500.00K | 500.00K |
| Total Debt Repaid | -2.10M | -3.63M | -3.14M | -3.08M | -3.00M |
| Issuance of Common Stock | 6.30M | 6.30M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.37M | -2.51M | -3.41M | -3.74M | -3.79M |
| Cash from Financing | 2.80M | 163.50K | -4.68M | -4.53M | -4.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.36M | 12.08M | 4.52M | 5.63M | 6.50M |